Magsayo, Joelyn D.

HRN: 27-37-08  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2026
CO-AMOXICLAV 625MG (TAB)
02/19/2026
02/26/2026
PO
625mg
BID X 7 Days
S/P NSVD With RMLE
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines